IMMUNITRACK ApS - CVR: 32347908

2022, DKK

10.07.2023

Bruttoresultat

5.257'

Primær drift

-191'

Årets resultat

-194'

Aktiver

21.096'

Kortfristede aktiver

8.804'

Egenkapital

12.846'

Afkastningsgrad

-1 %

Soliditetsgrad

61 %

Likviditetsgrad

174 %

Resultat

10.07.2023

Årsrapport	2022 10.07.2023	2021 10.11.2022	2020 30.09.2021	2019 29.09.2020	2018 31.10.2019	2017 25.10.2018	2016 31.10.2017	2015 28.10.2016
Nettoomsætning
Bruttoresultat	5.257.297	5.476.278	4.533.453	1.089.608	-457.365	2.450.285	1.016.932	482.591
Resultat af primær drift	-191.181	1.011.495	321.865	-1.502.719	-2.991.937	2.177.020	313.158	31.610
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0	0	0	0	0
Finansielle indtægter	132.758	483.242	68	1.252	53.187	0	0	0
Finansieringsomkostninger	-221.813	-211.038	-265.917	-71.615	-8.864	-24.190	0	0
Andre finansielle omkostninger	0	0	0	0	0	0	7.318	2.420
Resultat før skat	-325.145	1.283.699	56.016	-1.573.082	-2.947.614	2.152.830	0	0
Resultat	-194.097	1.175.601	256.541	-1.229.951	-2.303.315	1.676.895	238.536	22.671
Forslag til udbytte	0	0	0	0	0	0	0	0

Aktiver

10.07.2023

Årsrapport	2022 10.07.2023	2021 10.11.2022	2020 30.09.2021	2019 29.09.2020	2018 31.10.2019	2017 25.10.2018	2016 31.10.2017	2015 28.10.2016
Kortfristede varebeholdninger	0	0	0	0	0	0	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	5.458.637	2.934.524	4.889.474	1.523.359	747.853	762.223	484.793	355.005
Likvider	3.345.606	6.129.433	4.628.890	2.869.434	5.515.663	1.687.327	124.887	245.888
Kortfristede aktiver	8.804.243	9.063.957	9.518.364	4.392.793	6.263.516	2.449.550	609.680	600.893
Immaterielle aktiver og goodwill	7.653.297	4.442.073	2.372.148	2.417.962	2.066.000	2.093.920	439.562	2.136
Finansielle anlægsaktiver	2.438.305	641.982	43.703	0	27.600	0	0	0
Materielle aktiver	2.200.558	1.401.697	558.939	445.793	544.682	506.583	64.056	90.125
Langfristede aktiver	12.292.160	6.485.752	2.974.790	2.863.755	2.638.282	2.600.503	503.618	92.261
Aktiver	21.096.403	15.549.709	12.493.154	7.256.548	8.901.798	5.050.053	1.113.298	693.154

Aktiver

10.07.2023

Passiver

10.07.2023

Årsrapport	2022 10.07.2023	2021 10.11.2022	2020 30.09.2021	2019 29.09.2020	2018 31.10.2019	2017 25.10.2018	2016 31.10.2017	2015 28.10.2016
Forslag til udbytte	0	0	0	0	0	0	0	0
Egenkapital	12.845.920	10.159.857	7.672.440	4.878.360	6.108.311	3.545.083	287.938	49.402
Hensatte forpligtelser	673.918	0	0	0	0	483.342	58.799	0
Langfristet gæld til banker	0	0	0	0	0	0	0	0
Anden langfristet gæld	1.924.712	2.166.543	1.942.352	0	0	0	0	0
Leverandører af varer og tjenesteydelser	244.607	444.984	313.636	263.248	500.239	91.718	112.554	73.807
Kortfristede forpligtelser	5.051.766	3.223.309	2.878.362	2.378.188	2.773.271	955.577	766.561	643.752
Gældsforpligtelser	7.576.565	5.389.852	4.820.714	2.378.188	2.793.487	1.021.628	766.561	643.752
Forpligtelser	7.576.565	5.389.852	4.820.714	2.378.188	2.793.487	1.021.628	766.561	643.752
Passiver	21.096.403	15.549.709	12.493.154	7.256.548	8.901.798	5.050.053	1.113.298	693.154

Passiver

10.07.2023

Nøgletal

10.07.2023

Årsrapport	2022 10.07.2023	2021 10.11.2022	2020 30.09.2021	2019 29.09.2020	2018 31.10.2019	2017 25.10.2018	2016 31.10.2017	2015 28.10.2016
Afkastningsgrad	-0,9 %	6,5 %	2,6 %	-20,7 %	-33,6 %	43,1 %	28,1 %	4,6 %
Dækningsgrad	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Resultatgrad	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Egenkapitals-forretning	-1,5 %	11,6 %	3,3 %	-25,2 %	-37,7 %	47,3 %	82,8 %	45,9 %
Payout-ratio	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	-86,2 %	479,3 %	121,0 %	-2.098,3 %	-33.753,8 %	8.999,7 %	Na.	Na.
Soliditestgrad	60,9 %	65,3 %	61,4 %	67,2 %	68,6 %	70,2 %	25,9 %	7,1 %
Likviditetsgrad	174,3 %	281,2 %	330,7 %	184,7 %	225,9 %	256,3 %	79,5 %	93,3 %

Resultat

10.07.2023

Gæld

10.07.2023

Årsrapport

10.07.2023

Nyeste:01.06.2022- 31.05.2023(offentliggjort: 10.07.2023)

Information om virksomhedens regnskabsklasse:The annual report of Immunitrack ApS for 2021/22 has been prepared in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B with optional provisions from higher reportingclasses. The accounting policies applied are consistent with those of last year. The annual report for 2021/22 is presented in kr.

Oplysning om pantsætninger og sikkerhedsstillelser:The company has issued company mortgages for total amount 2,000,000, that have been provided as a security for debt to "Vækstfonden" totalling 2,254,526. The company mortgages covers certain fixed assets, etc., receivables from sales and services and intangible fixed assets. The carrying amount of assets covered by the company mortgage are: Fixed assets: DKK 1,028,708 Receivebles from sales: DKK 3,041,361.

Beretning

10.07.2023

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:The supervisory board and executive board have today discussed and approved the annual report of Immunitrack ApS for the financial year 1 June 2022 - 31 May 2023.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:Business review Immunitrack is a commercially active biotech company covering three major business areas including (i) provision of research and development services to pharma and biotechnology companies and academic research groups interested in mapping epitopes from cancer, virus and therapeutics that can elicit an adaptive immune response, (ii) advancing of novel TCR like antibodies (TCRLA) and (iii) development of novel AI software platform for more accurate prediction of T cell epitopes.